Table 2.

Unadjusted and adjusted odds ratios for cervical cancer progression by HIV status among patients seen at the Cancer Diseases Hospital in Lusaka, Zambia (HIV- negative as the reference).

Model	N	OR (HIV +vs HIV -)	95% CI	C-statistic
Model 1*	438	1.23	0.81,1.86	0.525
Model 2**	332	1.04	0.57,1.92	0.786

^*Model 1: Unadjusted with only HIV status included in the model.

^†Model 2: Adjusted model with HIV status, age, stage, brachytherapy doses received, EBRT doses received, chemotherapy cycles received, baseline creatinine, platelet, hemoglobin and white blood cell count, and follow-up time.